Treatment for High Clinical Suspicion of Influenza Despite Negative Rapid Antigen Test

Key Principles

The Centers for Disease Control and Prevention (CDC) recommends initiating empiric antiviral treatment with oseltamivir immediately when clinical suspicion for influenza is high, regardless of negative rapid antigen testing, as rapid tests have poor sensitivity (10-51%) and cannot exclude the diagnosis 1, 2, 3
The American Academy of Pediatrics suggests that rapid antigen tests have low sensitivity for influenza, particularly for H1N1 strains, and negative results should never be used to make treatment decisions or rule out influenza 1, 3, 4

The CDC recommends starting oseltamivir (Tamiflu) as soon as possible without waiting for confirmatory testing when influenza is clinically suspected, with a standard adult dosing of 75 mg orally twice daily for 5 days 2, 5
The American Academy of Pediatrics recommends pediatric dosing of oseltamivir as follows: ≤15 kg: 30 mg twice daily, >15-23 kg: 45 mg twice daily, >23-40 kg: 60 mg twice daily, >40 kg: 75 mg twice daily 4, 3

The CDC states that all patients at high risk for complications should receive antiviral treatment regardless of test results, including hospitalized patients, patients with severe or complicated illness, immunocompromised patients, pregnant women, adults ≥65 years of age, children <2 years of age, and patients with chronic medical conditions 2, 5

The CDC recommends that treatment is most effective when started within 24 hours of symptom onset, but hospitalized patients benefit even when treatment is delayed beyond 48 hours 2, 5

The Infectious Diseases Society of America recommends a standard treatment duration of 5 days for uncomplicated influenza, but considers longer treatment courses for immunocompromised patients, hospitalized patients with severe disease, and patients with documented persistent viral shedding 1, 5

The Infectious Diseases Society of America suggests investigating bacterial coinfection if patients present with severe disease, deteriorate after initial improvement, or fail to improve after 3-5 days of antiviral treatment, and empirically treating bacterial coinfection with appropriate antibiotics in addition to continuing antiviral therapy 5